Prostate cancer: Novel genetic and immunologic biomarkers
Prostate cancer (PCa) is considered one of the most prevalent male malignancies
worldwide with a global burden estimated to increase over the next two decades. Due to …
worldwide with a global burden estimated to increase over the next two decades. Due to …
Immunological analysis of Interleukin-10 (IL-10), tumor necrosis factor-a (TNF-a), and Prostate-specific antigen (PSA) in benign and malignant prostate cancer
ASH Al-Nasralla, SS Hussian… - Human Antibodies, 2023 - content.iospress.com
OBJECTIVE: The present study aimed to determining the relationship between the level of
cytokines (IL-10 and TNF-a) and PSA in the sera of patients and compared it with healthy …
cytokines (IL-10 and TNF-a) and PSA in the sera of patients and compared it with healthy …
Compressed Prostate Cancer Cells Decrease Osteoclast Activity While Enhancing Osteoblast Activity In Vitro
VJB van Santen, B Zandieh Doulabi… - International Journal of …, 2023 - mdpi.com
Once prostate cancer cells metastasize to bone, they perceive approximately 2 kPa
compression. We hypothesize that 2 kPa compression stimulates the epithelial-to …
compression. We hypothesize that 2 kPa compression stimulates the epithelial-to …
Phytosterol-enriched fraction of Morinda lucida extract inhibits testosterone-induced benign prostatic hyperplasia in rats.
JA Salemcity, KE Adewole, OA Falade… - Journal of Phytomedicine …, 2024 - ajol.info
Benign prostatic hyperplasia (BPH) is a prevalent disorder among ageing men and could
lead to prostatic carcinoma if not managed early and properly. Although orthodox drugs …
lead to prostatic carcinoma if not managed early and properly. Although orthodox drugs …